StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3063% above fair value
$21.12−0.11 (-0.52%)

Close on Nov 17, 2026Market cap $6.74BP/E 43.1Yield –

Amneal Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Amneal Pharmaceuticals's market cap was $7.11B on Nov 11, 2026, against $4.01B a year earlier. Over the last 5 years it ranged from $209.81M to $7.11B, with a median of $1.43B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.11B+76.2%
2025Dec 31, 2025$4.03B+73.9%
2024Dec 31, 2024$2.32B+147.3%
2023Dec 29, 2023$938.07M+211.9%
2022Dec 30, 2022$300.79M-58.3%
2021Dec 31, 2021$721.23M+7.9%
2020Dec 31, 2020$668.21M+7.9%
2019Dec 31, 2019$619.19M-28.3%
2018Dec 31, 2018$863.67M–

More Amneal Pharmaceuticals figures

See a number that looks wrong?